NIH guts its first and largest study centered on women

The Women’s Health Initiative (WHI) has enrolled tens of thousands of participants in clinical trials of hormones and other medications and tracked the health of many thousands more over more than 3 decades. Its findings have had a major influence on health care. WHI leaders announced yesterday that contracts supporting its regional centers are being terminated in September and that the study’s clinical coordinating center, based at the Fred Hutchinson Cancer Center, “will continue operations until January 2026, after which time its funding remains uncertain.”